• GLP-1 (9-36) Amide: Assay Interpretation

  2026-09-30

  GLP-1 (9-36) amide is a glucagon-like peptide-1 receptor antagonist for dissecting receptor-dependent cAMP responses. This guide translates receptor promiscuity findings into practical assay controls, peptide-handling decisions, and more defensible metabolic research conclusions.

• Sodium dicloxacillin monohydrate workflows

  2026-09-29

  Build reproducible MSSA experiments around a narrow-spectrum β-lactam with explicit control of strain, compartment, pH, and exposure. This guide combines antibacterial assay design with a practical spectrophotometric quality-control perspective for research workflows.

• RepSox for iPSC Differentiation Workflows

  2026-09-29

  RepSox provides a precise way to interrogate ALK5-dependent TGF-β signaling during induced pluripotent stem cell reprogramming and differentiation. This guide separates validated platelet-production advances from RepSox pilot applications, giving researchers practical setup, dosing, controls, and troubleshooting strategies.

• O-GlcNAcylation, Wnt, and Bone Formation

  2026-09-28

  The reference study identifies O-GlcNAcylation as a causal link between Wnt signaling, aerobic glycolysis, and osteoblast-mediated bone formation. Its evidence places PDK1 Ser174 O-GlcNAcylation and protein stabilization downstream of Wnt3a, providing a mechanistic framework for studying metabolic control of osteogenesis.

• Dorsomorphin for Hypoxia-Linked AMPK Studies

  2026-09-28

  Use Dorsomorphin (Compound C) to test whether AMPK signaling contributes to hypoxia-associated macrophage polarization and choroid plexus barrier dysfunction—not as a stand-alone proof of mechanism. This guide connects a recent mouse study to a practical, control-rich workflow and highlights the compound’s BMP-pathway activity as an important interpretation check.

• Optimizing hiPSC-Derived Functional Platelet Production

  2026-09-27

  Yue and colleagues combined increased embryoid-body input, human platelet lysate, small-molecule substitutions for selected cytokines, and maturation-promoting compounds to improve platelet differentiation from human induced pluripotent stem cells. Their optimized scheme produced functional platelets in 19 days, increased reported yield, and reduced production costs, while leaving important questions about reproducibility and clinical translation unresolved.

• CHIR 99021 Trihydrochloride for Organoids

  2026-09-26

  Use CHIR 99021 trihydrochloride as a controlled GSK-3 perturbation to test how organoid self-renewal, proliferation, and differentiation respond to pathway modulation. A concentration-ranging, vehicle-matched workflow helps separate useful shifts in cell state from toxicity or culture-to-culture variation.

• Tobramycin as a Probe of Resistance Phenotypes

  2026-09-25

  Tobramycin is an aminoglycoside antibiotic that can help researchers connect ribosomal inhibition with measurable bacterial susceptibility. This article looks beyond potency rankings to show how historical clinical-isolate data can inform assay design—and where those data should not be overinterpreted.

• Birinapant (TL32711): Designing Apoptosis Experiments

  2026-09-25

  Birinapant (TL32711) provides a way to interrogate IAP-controlled apoptosis without conflating it with p53-dependent cell-death signaling. This article connects its mechanism to colorectal cancer chemoradiotherapy research and offers a cautious framework for experimental design.

• Pepstatin A: From Protease Mechanism to Translation

  2026-09-24

  Pepstatin A can help researchers test whether aspartic protease activity contributes to viral protein processing or osteoclastogenesis. This article connects its mechanism and reported assay conditions to practical experimental design, evidence boundaries, and a broader lesson in cost-conscious data generation.

• WIP1–p38 MAPK Control of Pyroptosis in Septic AKI

  2026-09-24

  This study identifies WIP1 as a potential brake on renal tubular pyroptosis in sepsis-associated acute kidney injury, linking its inhibitory effect to p38 MAPK signaling. Evidence from human tissue, LPS-challenged kidney cells, and mice supports the proposed pathway, while leaving its therapeutic relevance and molecular details for further testing.

• AG-490 and Exosomal SNORD52: Testing JAK2/STAT6

  2026-09-23

  AG-490 (Tyrphostin B42) offers a pharmacological way to probe kinase signaling, but interpreting its effects in exosome-driven macrophage biology requires careful controls. This article connects recent HCC-derived SNORD52 findings to practical assay design and explains what inhibitor responses can—and cannot—show.

• Caspase-3–NDUFS1 Axis in Trichothecene ROS

  2026-09-23

  This preprint identifies caspase-3-mediated cleavage of mitochondrial complex I subunit NDUFS1 as a driver of ROS accumulation and mitochondrial injury after deoxynivalenol or T-2 toxin exposure. It also connects ERO1α-dependent endoplasmic reticulum oxidative stress with mitochondrial damage, providing a mechanistic framework for studying trichothecene-induced hepatotoxicity while requiring validation because the work has not yet been peer reviewed.

• T7 RNA Polymerase for Translational RNA Design

  2026-09-22

  How promoter-specific RNA synthesis can strengthen mechanistic studies of HEY2, mitochondrial respiration, and cardiac homeostasis while improving translational research workflows.

• CAY10499: Lipase Inhibitor Guide

  2026-09-22

  A scenario-based guide to using CAY10499, a potent inhibitor of human hormone sensitive lipase and monoglyceride lipase, in lipid-linked viability, proliferation, and cytotoxicity workflows. It explains assay interpretation, solvent controls, protocol optimization, and selection of SKU B7841 for reproducible laboratory studies.

555 records 3/37 page Previous Next 12345 下5页 Last page